Getinge (OTCMKTS:GNGBY) Sets New 12-Month High – Here’s What Happened

Getinge (OTCMKTS:GNGBY) reached a new 52-week high during trading on Tuesday . The company traded as high as $24.05 and last traded at $23.8450, with a volume of 1434 shares traded. The stock had previously closed at $23.54.

Wall Street Analysts Forecast Growth

Separately, Nordea Equity Research upgraded shares of Getinge from a “hold” rating to a “buy” rating in a research report on Wednesday, October 22nd. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Getinge Price Performance

The company has a debt-to-equity ratio of 0.31, a current ratio of 1.34 and a quick ratio of 0.80. The firm has a market cap of $6.49 billion, a price-to-earnings ratio of 31.79 and a beta of 1.06. The stock’s fifty day moving average price is $22.82 and its 200-day moving average price is $21.81.

Getinge (OTCMKTS:GNGBY) last posted its quarterly earnings data on Tuesday, October 21st. The company reported $0.25 earnings per share for the quarter. The firm had revenue of $864.74 million for the quarter. Getinge had a net margin of 5.77% and a return on equity of 10.64%.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.